Zydus Therapeutics announces positive topline results from EPICS-III Phase 2b/3 trial of… EP News Bureau Aug 29, 2025 EPICS-III trial met primary and secondary endpoints in evaluating Saroglitazar for Primary Biliary Cholangitis patients with…
